Abstract: A machine for making tissue contains: a forming section with a fabric for dewatering and transporting a nascent tissue web; a through air drying section with at least one through air drying unit; and a Yankee section with a Yankee cylinder. The through air drying section contains a through air drying (TAD) fabric for taking over the tissue web from the fabric of the forming section, and for transporting the tissue web through the at least one through air drying unit towards the Yankee section. The TAD fabric is constructed as a spiral link fabric which spiral link fabric is free of any coating or the like.

Abstract: A method and apparatus for protecting receiver circuitry from damage from interference signals. The apparatus includes a digital step attenuator (DSA) configured to attenuate a received signal, an over-voltage detector configured to detect a peak of the received signal at an input of receiver circuitry and activate an over-voltage detection signal if the peak of the received signal exceeds a detection threshold, and a digital control block configured to send a control code to the DSA to control an attenuation step of the DSA. The digital control block sends a control code to set the attenuation step of the DSA at a pre-configured attenuation step in response to the over-voltage detection signal asserted by the over-voltage detector. The pre-configured attenuation step is set to a level that can protect the receiver circuitry from the interference signals.

Abstract: Disclosed herein is an apparatus of a radio communication device, where the apparatus may include a plurality of signal paths, each signal path of the plurality of signal paths is configured to receive a radio frequency, RF, signal from a corresponding RF circuit. The apparatus may also include a processor configured to determine first signal paths and a second signal path from the plurality of signal paths, wherein the first signal paths are configured to receive first RF signals of the RF signals. The processor may also be configured to demodulate the first RF signals received from the first signal paths to decode received communication data; perform, for a frequency band, an RF environmental sensing operation based on a digital signal converted from a second RF signal of the RF signals, wherein the second RF signal is provided by the second signal path.

Abstract: Proposed is a street address signage device, for commercial or residential use, wherein said street address signage device is configured to be affixed to a building, or another structure or an auxiliary edifice on a residence or property, for enhanced wayfinding purposes. The primary purpose of the device is to clearly and brilliantly display a street address during all lighting and weather conditions to passing traffic or anyone within the vicinity. The secondary purpose is to alert and/or advertise with excessive/aggressive means, to anyone within eyesight of said residence or property, a heightened-need beacon or distress symbol or specialized display. In a most preferred embodiment the heightened need is an emergency situation. In said most preferred embodiment said primary purpose comprises displaying numbers on a lighted front screen and said secondary purpose comprises flashing or strobing bright lights.

Abstract: The present invention relates to a process for making an extract of Linum usitatissimum seeds. Furthermore, it relates to the extract itself and to a cosmetic composition comprising this extract. Furthermore, it relates to the use of this extract or of the cosmetic composition comprising this extract for hair styling or for conditioning or for protection against UV radiation.

Abstract: Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and sapoviruses within the Caliciviridae family of viruses. The ex vivo culture systems include intestinal enteroids in combination with bile or a functionally active fraction or component thereof. In specific embodiments, the culture system is utilized to test inactivation compounds for therapeutic or environmental efficacy and to test contaminated comestibles and/or environmental entities for determination of the presence of infectious virus. Furthermore, antiviral compositions may be tested using systems of the disclosure, including drugs, small molecule inhibitors, and biologics such as neutralizing monoclonal antibodies.

Abstract: The disclosure herein relates to systems, methods, and devices for estimating a total estimated power consumption of a wireless modem. The power estimation may include determining a static power consumption estimate based on configuration parameters of modem subcomponents of a wireless modem. The power estimation may also include determining a dynamic power consumption estimate based on a sum of, for each corresponding active power amplifier of the wireless modem, a predefined power offset associated with a current reported power level for the corresponding active power amplifier and a maximum transmit power of a predefined range associated with the current reported power level of the active power amplifier. The power estimation may also include combining the static power consumption estimate and the dynamic power consumption estimate as the total estimated power consumption of the wireless modem.

Abstract: A device includes a camera sensor and an illumination source structure. The illumination source structure is positioned to emit light towards a field of view of the camera sensor. The illumination source structure includes a bore, internal threads extending along at least a portion of a length of the bore, and a light emitting diode (LED) positioned within the bore such that the internal threads encircle a lens of the LED.

Abstract: Methods of using viruses labeled with alkyne-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to increase the infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an alkyne-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The viruses labeled with alkyne-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.

Abstract: Described herein are methods and compositions for use in improving a vascular barrier of endothelial cells. The methods may include the use of barrier agonist compounds and improved techniques for culturing endothelial cells. The improved methods and compositions for culturing endothelial cells may include at least one or more of the following: an adenylyl cyclase activator; an activator of Sphingosine-1-phosphate (S1P) receptor internalization; a direct or indirect inducer of tight junction protein expression, and a direct or indirect inducer of adherens junction protein expression.

Abstract: Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and sapoviruses within the Caliciviridae family of viruses. The ex vivo culture systems include intestinal enteroids in combination with bile or a functionally active fraction or component thereof. In specific embodiments, the culture system is utilized to test inactivation compounds for therapeutic or environmental efficacy and to test contaminated comestibles and/or environmental entities for determination of the presence of infectious virus. Furthermore, antiviral compositions may be tested using systems of the disclosure, including drugs, small molecule inhibitors, and biologics such as neutralizing monoclonal antibodies.

Abstract: This invention is directed to polymer-permeated grafts, including those which contain an active which provide for the controlled or sustained release thereof, and methods of making and using the same.

Abstract: Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and sapoviruses within the Caliciviridae family of viruses. The ex vivo culture systems include intestinal enteroids in combination with bile or a functionally active fraction or component thereof. In specific embodiments, the culture system is utilized to test inactivation compounds for therapeutic or environmental efficacy and to test contaminated comestibles and/or environmental entities for determination of the presence of infectious virus. Furthermore, antiviral compositions may be tested using systems of the disclosure, including drugs, small molecule inhibitors, and biologics such as neutralizing monoclonal antibodies.

Abstract: An apparatus of user equipment (UE) includes a radio integrated circuit (IC), an adjustable external low noise amplifier (eLNA) external to the radio IC, and processing circuitry. The radio IC includes a receive signal circuit path including an adjustable gain internal low noise amplifier (iLNA), and a transmit signal circuit path including a digital-to-analog converter (DAC) circuit configured to convert digital signals to analog baseband signals for transmitting. The processing circuitry is configured to provide digital values of the digital signals to the DAC circuit and initiate adjusting gain of one or both of the iLNA and the eLNA according to the digital values.

Abstract: The present invention relates to a device for the collection of breath and/or air and the processing and analysis of analytes contained therein. More particularly, the present invention relates to a method of collecting exhaled breath and/or air and processing and analyzing one or more analytes contained therein.

Abstract: A medical device may include a shaft, and a first tool extending from a distal end of the shaft. The medical device also may include a control assembly coupled to the shaft. The control assembly may include a console, a first grip extending proximally from the console, and a second grip extending proximally from the console. The control assembly also may include a first deflection actuator configured to deflect the first tool about a longitudinal axis of the first tool, a first rotation actuator configured to rotate the first tool about the longitudinal axis of the first tool, and a first longitudinal actuator configured to move the first tool along the longitudinal axis of the first tool.

Abstract: The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium aerogel particles comprising an alginate, as well as the cosmetic use of a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium aerogel particles comprising an alginate, for treating the skin.

Abstract: Methods of using viruses labeled with alkyne-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to increase the infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an alkyne-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The viruses labeled with alkyne-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.

Abstract: Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and sapoviruses within the Caliciviridae family of viruses. The ex vivo culture systems include intestinal enteroids in combination with bile or a functionally active fraction or component thereof. In specific embodiments, the culture system is utilized to test inactivation compounds for therapeutic or environmental efficacy and to test contaminated comestibles and/or environmental entities for determination of the presence of infectious virus. Furthermore, antiviral compositions may be tested using systems of the disclosure, including drugs, small molecule inhibitors, and biologics such as neutralizing monoclonal antibodies.

Abstract: An apparatus of user equipment (UE) includes a radio integrated circuit (IC), an adjustable external low noise amplifier (eLNA) external to the radio IC, and processing circuitry. The radio IC includes a receive signal circuit path including an adjustable gain internal low noise amplifier (iLNA), and a transmit signal circuit path including a digital-to-analog converter (DAC) circuit configured to convert digital signals to analog baseband signals for transmitting. The processing circuitry is configured to provide digital values of the digital signals to the DAC circuit and initiate adjusting gain of one or both of the iLNA and the eLNA according to the digital values.